Contrary to the beneficial role of KLRG-1+CD57+CD4+ senescent Th cells in breast cancer patients, Ye et al. showed that tumor-derived γδ T cells induce senescence in CD4+ T cells and also in DCs that were no longer able to process and present tumor antigens to T cells. Here, CD4 is linked to breast cancer.